FDA Mounjaro FDA Prescribing Information sNDA 215866s031, section 6.2 (Postmarketing), Feb 2025
It is expected to be administered weekly, starting with a lower dose to minimise side effects (1)
Tirzepatide access is growing, but coverage may vary
Meta-analysis data shows that semaglutide increases gallbladder-related disorders, particularly cholelithiasis (gallstones), by over 2.6 times compared to placebo
Apple cider vinegar delays stomach emptying, prolonging the GLP-1 trickle
Its also important to note that, in addition to taking weekly doses of semaglutide, participants made lifestyle changes